Three Campylobacter jejuni, biotype 2, serotype O:41 strains that were isolated from patients who developed Guillain-Barré syndrome (GBS) and one C. jejuni isolate from a patient who developed enteritis only were examined. The aim of the study was to determine the structure of the core oligosaccharide ( 
Guillain-Barré syndrome (GBS) is characterized as an acute, inflammatory polyneuropathy (48) , and approximately twothirds of GBS patients develop the syndrome following various infections of the respiratory or gastrointestinal tract (27) . GBS is clinically very heterogeneous, and several variants of the disease occur and include both acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). Campylobacter jejuni, a leading cause of acute gastroenteritis in humans, has been identified as the single most important predisposing factor associated with the development of GBS and occurs in up to 66% of patients (20, 27, 29, 47) . Characteristically, 76% of the AMAN and 42% of the AIDP GBS patients have serologic evidence consistent with recent C. jejuni infection (17, 30) .
C. jejuni can be serotyped based on differences in the saccharide structure (O side chain and core oligosaccharide [OS] ) of the lipopolysaccharide (LPS; O antigen) of the bacterium (32, 45, 46) . Some reports suggest that only specific C. jejuni serotypes are associated with GBS. A predominance of C. jejuni O:19, an uncommon serotype in gastroenteritis patients, has been found in Japanese GBS patients (23, 24) . Similarly, Fujimoto et al. (11) (24, 37, 39, 43, 49) . C. jejuni O:2, O:10, and O:23 (19, 52, 66) have been found in association with MillerFisher syndrome, a variant of GBS comprising areflexia, ataxia, and ophthalmoplegia without limb weakness (50) .
Serum antibodies against gangliosides have been observed in about 30% of GBS patients (27, 70) . The structures of the major human gangliosides are shown in Fig. 1 . Autoreactive antibodies to gangliosides, especially the GM 1 ganglioside, occur in GBS patient sera after C. jejuni infection during the acute phase of the illness (14, 19, 41, 42, 54, 64, 69, 70) . Conversely, antiganglioside antibodies, including those in sera from GBS patients, cross-react with LPSs of C. jejuni serotypes associated with GBS (19, 54) . Antiganglioside antibodies may be involved in the pathogenesis of GBS because some individuals have developed GBS-like symptoms after the administration of gangliosides (10, 18, 59) and, moreover, because plasma exchange and administration of intravenous immunoglobulin (Ig) elicit a beneficial response (59) .
Chemical studies on LPS extracted from C. jejuni have shown that the structures of the terminal regions of the core OSs of specific serotypes mimic the structures of human gangliosides (2, 5, 6, 37) , and research has focused on the view that molecular mimicry may be a factor in the pathogenesis of GBS (37) . Furthermore, the core OSs of LPSs of C. jejuni O:19 isolates have been shown to mimic human gangliosides GM 1 , GD 1a , GT 1a , and GD 3 (2, 3, 33, 64, 68) . GM 2 -like OS structures occur in LPSs from serostrains O:1, O:23, and O:36 (6) , whereas the core OS of C. jejuni serostrain O:4 mimics the GD 1a ganglioside (6, 69) . However, mimicry of C. jejuni O:2 is limited to that of a disaccharide which is present in a range of gangliosides including GD 1a (4) .
The present study describes the characterization of C. jejuni strains belonging to serotype O:41, three recovered from patients who developed GBS and one recovered from a patient who developed enteritis only. In particular, the presence of ganglioside-like epitopes in the LPSs of these strains was in-vestigated and the chemical structure of the core OS of one strain was established.
MATERIALS AND METHODS

Patients.
The clinical details of patients at Groote Schuur Hospital (GSH) and Red Cross Hospital (RXH) in Cape Town, South Africa, from whom C. jejuni was isolated have been described previously (26) . Briefly, a 26-year-old male (patient A) from whom C. jejuni 16971.94GSH was isolated developed GBS 10 days after an episode of diarrhea. A cerebrospinal fluid (CSF) study performed in the first 48 h of illness was normal, and electromyogram studies showed evidence of a severe predominately motor polyneuropathy with axonal loss. There was no sensory or bulbar involvement. A 22-month-old female (patient B) from whom C. jejuni 260.94RXH was isolated from a formed stool developed a more severe type of GBS. After ventilation and prolonged hospitalization, the patient progressed well with no relapse. A 29-year-old female (patient C), from whom C. jejuni 28134.94GSH was isolated, had suffered an episode of GBS at the age of 10 years. She had a history of upper respiratory tract infections. Her CSF characteristics were normal, and neurological tests showed evidence of a diffuse motor neuropathy with both demyelinating and axonal elements. C. jejuni 176.83 was isolated from a 9-year-old female (patient D) who developed enteritis but did not subsequently develop GBS.
Bacterial strains and growth conditions. Isolation of Campylobacter strains involved filtration and incubation in an H 2 -enriched microaerobic atmosphere (GasPak BR38 [Oxoid Ltd., London, England] without a catalyst) according to an established protocol (26) . Gram-negative, motile, spiral or curved rods were cultured and maintained on blood agar (tryptose agar base [Oxoid] with 10% unlysed horse blood) under microaerobic conditions as described previously (38) . C. jejuni serostrains O:2 (ATCC 43430), O:3 (ATCC 43431), and O:19 (ATCC 43446) were obtained from the American Type Culture Collection (Manassas, Va.). Strains were routinely grown on blood agar in a manner identical to that described above. Bacterial biomass was harvested, and bulk extraction of LPS was performed by the phenol-water extraction procedure described previously (38, 61) .
Biotyping and serotyping. Bacterial identification was accomplished by established procedures (33, 46, 56) . Isolates were biotyped by the scheme of Skirrow and Benjamin (56) . Serotyping on the basis of thermostable somatic O antigens was performed with the 66 antisera of the Penner scheme (46) and an additional 30 antisera to new serotypes not included in the Penner scheme.
Hemolysis assay. Hemolytic activity was screened by inoculating bacteria onto blood agar (tryptose agar base [Oxoid] with 2% horse blood) and incubating them at 42°C for 48 h (26) .
Invasion assay. The invasiveness of C. jejuni isolates was determined according to the method of Wassenaar et al. (60) . Briefly, intestinal cells (INT-407; Flow Laboratories, Herts, England) were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Grand Island, N.Y.), supplemented with 10% (vol/vol) fetal calf serum, penicillin (100 IU/ml), and streptomycin (100 g/ml). The invasion assay was performed in 35-mm-diameter tissue culture dishes.
Confluent monolayers (about 10 6 cells) were washed 30 min prior to infection with DMEM without supplements. A bacterial suspension in DMEM was added to each dish to give a multiplicity of infection of 10 3 bacteria per cell. Control experiments were performed with DMEM alone. Infected monolayers were incubated at 37°C for 2 h in an atmosphere of 95% air-5%CO 2 to allow bacteria to adhere to the cells. After incubation, monolayers were washed five times with DMEM and reincubated for another 3 h with DMEM containing 250 g of gentamicin per ml. Following this second incubation, the monolayers were washed three times with phosphate-buffered saline (PBS; pH 7.4; Oxoid) and lysed in 0.5% Triton X-100. The suspensions were diluted, and the numbers of CFU were calculated. Colonies were confirmed as being C. jejuni by standard CFU procedures (33, 46, 56) .
Proteinase K digestion. A procedure modified from that of Hitchcock and Brown (16) was used for the enzymatic digestion of whole-cell lysates. Bacteria were cultured on blood agar, harvested in PBS (pH 7.4), and diluted to an A 600 of 0.3. Quantities of 1.5 ml were transferred to microtubes and centrifuged at 13,000 ϫ g for 5 min. The resultant pellets were solubilized in 200 l of lysing buffer (20% glycerol, 5% 2-␤-mercaptoethanol, 4.6% sodium dodecyl sulfate [SDS], 0.125 M Tris-hydrochloride-buffered saline [pH 6.8], 0.004% bromophenol blue). The lysate was heated to 100°C for 5 min and cooled to room temperature, and 40 l of a 2-mg/ml proteinase K solution (Sigma Chemical Co., St. Louis, Mo.) was added. The enzyme-treated lysates were incubated at 37°C for 1 h and subsequently heated at 100°C for 5 min prior to electrophoresis.
SDS-PAGE and immunoblotting. The discontinuous buffer system of Laemmli (25) was used to fractionate the LPS prepared by proteinase K digestion of whole-cell lysates and also to examine purified LPS. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed with a stacking gel of 5% acrylamide and a separation gel of 15% acrylamide containing 3.2 M urea (BDH Laboratory Supplies, Poole, England). Samples were electrophoresed at a constant current of 35 mA until the tracking dye was within 0.5 cm of the bottom of the gel. After SDS-PAGE, the gels were fixed and the LPS was detected by silver staining, as described previously (58) . Alternatively, LPS fractionated by SDS-PAGE was electrotransferred from gels to nitrocellulose membranes (pore size, 0.45 m; Bio-Rad Laboratories, Hercules, Calif.) by using the buffer system described by Towbin et al. (57) . Visualization of nitrocellulose blots was performed with rabbit antiserum as the first antibody and goat anti-rabbit IgGhorseradish peroxidase conjugate (Bio-Rad) as the second antibody (46) . (54, 65) were used as developers for gangliosides and LPS, respectively. Gangliosides and LPS were visualized by spraying plates with resorcinol-HCl reagent (55) .
Immunostaining. TLC with immunostaining was performed by the procedure of Saito et al. (51) , as modified by Schwerer et al. (54) . Briefly, developed TLC plates were dried for 30 min in a vacuum desiccator, fixed in 0.4% polyisobutylmethacrylate (Aldrich, Steinheim, Germany) in n-hexane (Merck) for 1.5 min, and dried as before. Lanes were overlaid with either rabbit antiserum to ganglioside GM 1 , GM 2 , or asialoGM 1 (Matreya Inc., Pleasant Gap, Pa.) or rabbit antiserum to C. jejuni O:41 diluted 1:100 in a solution of PBS (Oxoid), pH 7.4, containing 0.3% gelatin (gelatin-PBS). The TLC plates were incubated at 4°C overnight in a humid chamber, washed three times with cold PBS, overlaid with peroxidase-conjugated anti-rabbit IgG (Sigma) diluted 1:500 in gelatin-PBS, and incubated in a humid chamber at room temperature for 1 h with gentle rocking. The plates were washed with cold PBS and immersed in a horseradish peroxidase color development solution (Bio-Rad) consisting of 60 mg of 4-chloro-1-naphthol dissolved in 20 ml of methanol and added to 100 ml of Tris-hydrochloridebuffered saline containing 60 l of cold 30% aqueous H 2 O 2 until the immunoreactants became visible. The substrate reaction was stopped by washing the plates with cold PBS.
Binding experiments with cholera toxin (CT)-peroxidase conjugate (Sigma) and peanut agglutinin (PNA)-peroxidase conjugate (Kem-En-Tec, Copenhagen, Denmark) were performed under the same conditions as those described for immunostaining. However, only one overlay step with CT-peroxidase conjugate at a dilution of 1:1,000 or PNA-peroxidase conjugate at a dilution of 1:50 in gelatin-PBS was used.
Inhibition experiments were performed by a modified TLC technique whereby the B subunit of CT (Sigma) was diluted 1:250 in gelatin-PBS from a stock solution (1 mg/ml) and overlaid onto TLC plates. The plates were incubated for 1 h at room temperature with gentle rocking. Antiserum was subsequently overlaid overnight at 4°C onto the plates, and detection of immunoreactants was performed with horseradish peroxidase color development solution.
Immunoadsorption. Antiserum to C. jejuni O:41 was incubated with 200 g of ganglioside GM 1 or 200 g of LPS for 2 h at 37°C with rotation of the test tubes (Cell Major Mixer, model CM200). Immunoprecipitates were removed by centrifugation (10,000 ϫ g, 10 min), and supernatants were tested. The adsorbed antiserum was diluted 1:100 in gelatin-PBS before tests to measure residual IgG binding activity to GM 1 Determination of the chemical structure of C. jejuni O:41 LPS. One portion of purified LPS was de-O-acetylated with anhydrous hydrazine; a second portion was acid hydrolyzed, and the water-soluble material was fractionated by gel permeation chromatography (3). Briefly, purified LPS was dissolved in 5 ml of aqueous 1% acetic acid and hydrolyzed by heating at 100°C for 90 min. Precipitated lipid A was removed by centrifugation at 3,500 ϫ g for 1 h, the supernatant solution was freeze-dried, and the residue was redissolved in 2 ml of analyticalgrade water for fractionation by gel permeation chromatography on a Bio-Gel P-6 column (1.0 by 100 cm) (Bio-Rad) with water as the eluent. Fractions were monitored by measuring A 206 . In addition, fractions were assayed by the phenolsulfuric acid method for neutral carbohydrates (9) and the modified Ehrlich reaction assay for sialic acid (8) . The relevant fractions were pooled and were freeze-dried. Methylation analysis, chemical modifications of OSs, and Smith degradations were performed on the resultant material. Structural studies on the core OS derivatives used chemical analyses, nuclear magnetic resonance (NMR) spectroscopy, and electron impact mass spectrometry as reported previously for LPS from C. jejuni O:19 (3, 33) . Analysis using 1 H-and 13 C-NMR spectroscopy included recording one-and two-dimensional spectra.
RESULTS
Bacterial identification and classification. Biochemical reactions of the three C. jejuni strains isolated from GBS patients and of one C. jejuni strain isolated from an enteritis patient were characteristic of the species (56) . All four C. jejuni strains were biotype 2, according to the scheme of Skirrow and Benjamin (56) . Thermostable antigenic preparations of the isolates reacted with O:41 antisera with titers of up to 1:2,560 but did not react with the other C. jejuni typing antisera. As previously described (26) , the isolates were screened for hemolytic activity by incubation on tryptose blood agar, and invasiveness was measured by a tissue culture INT-407 invasion test. All the C. jejuni isolates were strongly hemolytic and strongly invasive (10 6 bacteria penetrated per 10 6 INT-407 cells). Furthermore, analysis of electrophoretic protein profiles and PCR-restriction fragment length polymorphisms of the GBS isolates has shown that these C. jejuni strains are completely different from other serotypes of C. jejuni biotype 2 and that they may be clonal (7, 26) . Restriction fragment end labelling of the serotype O:41 strains confirmed this finding (36) .
Yields of LPS. LPS was extracted according to established procedures (38, 61) , and for each strain, LPSs were obtained from both the water and phenol phases. The majority of LPS was isolated from the water phase, and yields of LPS from the phenol phase were minimal (up to 0.06%). Yields of purified LPS from the water phase differed slightly among strains. The greatest yield (dry weight) of LPS (6.8%) was obtained from C. jejuni 28134.94GSH. The other two GBS isolates yielded approximately 5.2% LPS. On the other hand, the enteritis isolate, C. jejuni 176.83, gave 4.8% LPS.
Electrophoretic patterns of C. jejuni serotype O:41 LPS.
Silver-stained SDS-PAGE gels of water-phase LPS from C. jejuni O:41 exhibited a pattern of bands migrating near the bottom of the gel, corresponding to low-molecular-weight (low-M r ) rough-form LPS composed of core OS and lipid A, but bands characteristic of high-M r LPS with O side chains were absent (Fig. 2) . As C. jejuni high-M r LPS is not visualized by the staining procedure of Tsai and Frasch (58) Assay for Neu5Ac. Differing amounts of N-acetylneuraminic acid (Neu5Ac) were detected in the LPSs of the three serotype O:41 GBS isolates by using the Ehrlich reaction assay (8) .
In the LPS of C. jejuni 16971.94GSH, 200 nmol of Neu5Ac per mg was found, whereas a smaller amount of Neu5Ac was detected in the LPSs of the other two isolates (C. jejuni 260.94RXH, 132 nmol/mg; C. jejuni 28134.94GSH, 101 nmol/ mg). The LPS of the enteritis isolate, C. jejuni 176.83, also contained Neu5Ac (114 nmol/mg). In addition, after methanolysis and peracetylation of the respective LPSs as described previously (38) , the presence of Neu5Ac was confirmed in the LPSs by detection of its peracetylated methyl ketoside methyl ester derivative by gas-liquid chromatography. Furthermore, during this analysis, the levels of sialylation in the respective LPSs were the same as those by the colorimetric assay.
Binding of rabbit antiganglioside antisera to LPS. As shown in Table 1 , the specificity of rabbit antisera was demonstrated by the strong reaction of anti-GM 1 antiserum with the GM 1 ganglioside and the weak reaction with GD 1b . Anti-asialoGM 1 antibodies reacted strongly with the asialoGM 1 ganglioside, and a weak reaction occurred with GM 1 . Anti-GM 2 antisera reacted only with the GM 2 ganglioside.
The reactions of antiganglioside antibodies with purified LPSs 
a ϩϩϩϩ, very strong reaction; ϩϩϩ, strong reaction; ϩϩ, moderate reaction; ϩ, weak reaction; (ϩ), barely visible reaction; -, no reaction. ND, not done.
are shown in Table 2 . Anti-GM 1 antiserum bound to purified serotype O:41 LPSs from the three GBS-associated isolates but also bound to serotype O:41 LPS purified from the enteritis isolate, suggesting the presence of a GM 1 -like epitope in these LPSs. The anti-GM 1 antibodies cross-reacted with serotype O:19 LPS and cross-reacted weakly with serostrain O:2 LPS. Anti-GM 1 antiserum did not react with the LPS of C. jejuni O:3, a strain whose LPS is not sialylated and which is not associated with the development of GBS (1, 38) .
Anti-asialoGM 1 antiserum showed a strong reaction with C. jejuni 260.94RXH LPS and weaker binding with each of the other serotype O:41 LPSs, including that from the enteritis isolate (Table 2) . A strong reaction of this antiserum was observed with serostrain O:2 LPS, and a weaker reaction occurred with serostrain O:19 LPS.
Anti-GM 2 antiserum bound the GM 2 ganglioside (Table 1 ) but did not bind to any serotype O:41 LPS, suggesting that this LPS does not have a GM 2 -like epitope (Table 2 ). This antiserum did not bind to serostrain O:2 or O:19 LPS, and antiganglioside antisera did not bind to serostrain O:3 LPS (Table  2) . Control rabbit antiserum did not bind to LPS or gangliosides (data not shown).
Binding of rabbit anti-C. jejuni O:41 antisera to gangliosides and LPS. Rabbit antiserum against C. jejuni 16971.94GSH showed a strong reaction with GM 1 and a much weaker reaction with asialo-GM 1 (Table 1) Binding of CT and PNA to gangliosides and LPS. CT, a ligand for the GM 1 ganglioside, and PNA, a ligand for the disaccharide moiety Gal␤1-3GalNAc, were tested for their abilities to react with a variety of gangliosides (Table 1) and C. jejuni LPS ( Table 2 ). In addition to a reaction with GM 1 , CT showed a weaker binding to asialoGM 1 Rabbit antibodies
a ϩϩϩϩ, very strong reaction; ϩϩϩ, strong reaction; ϩϩ, moderate reaction; ϩ, weak reaction; (ϩ), barely visible reaction; -, no reaction.
LPS confirms our earlier findings that GM 1 and O:41 LPS have similar epitopes. Composition and structure of LPS from C. jejuni 16971. 94GSH. An analysis of de-O-acylated LPS and material derived from hydrolyzed LPS and subsequent gel chromatography revealed saccharide chains consistent with the core OS of LPS molecules. Structural analyses established the structure of the core OS as shown in Fig. 4 . This core OS has a terminal tetrasaccharide mimicking that of ganglioside GM 1 (Fig. 1) ; this mimicry resembles that observed in certain C. jejuni O:19 GBS isolates (3, 33, 68) . The complete details of the chemical characterization of C. jejuni 16971.94GSH LPS will be published elsewhere (35) .
DISCUSSION
C. jejuni is a major cause of human gastroenteritis that is usually self-limiting, but in a small minority of cases GBS develops within 1 to 3 weeks after infection (20, 27) . The association of GBS with the preceding infection has led to a search for candidate bacterial antigens which may precipitate autoimmune responses in the host (15, 47, 62, 63) . Gangliosides have been extensively studied as possible host antigens for autoimmune disease since serum antibodies against gangliosides, especially GM 1 , are found during the acute phase of GBS when preceded by C. jejuni infection (14, 41, 48, 67, 70) . Molecular mimicry between core OSs of certain C. jejuni serotypes associated with GBS (O:2, O:4, and O:19) and gangliosides has been established (3, 4, 6, 33, 37, 38, 62, 68) . In Miller-Fisher syndrome studies, mimicry between a C. jejuni O:10 isolate and ganglioside GD 3 has been established (52) . Prompted by these previous findings, we undertook an investigation of the structure of the LPSs of C. jejuni isolates associated with GBS in South Africa. All three strains were strongly hemolytic and strongly invasive and may be clonal (26) . We also examined a C. jejuni isolate of the same serotype that was isolated from a patient with enteritis alone. Serotyping (45) identified the isolates as serotype O:41, a serotype previously not associated with neurological disease. Hot phenol-water extraction resulted in high yields of LPS (5 to 6.8% of the dry weight), which are close to the theoretical LPS content of gram-negative bacteria (40) . Although LPSs of C. jejuni strains were isolated from both the water and phenol phases of extracts, only minimal amounts of LPS were recovered from the phenol phase of C. jejuni serotype O:41 strains. Therefore, further studies were conducted only on the water phase LPS.
By SDS-PAGE analysis, C. jejuni serotype O:41 LPS from the three GBS isolates and the LPS from the enteritis isolate showed virtually identical rates of migration, reflecting core molecules with the same molecular weight. Sialic acid, i.e., Neu5Ac, is not commonly found in LPS but has been identified in C. jejuni LPS (6, 31, 38) . When present in LPS, Neu5Ac is more commonly encountered as a constituent of the core OS (6, 21, 22, 34, 38) 1 , and therefore the antibodies must recognize a similar epitope. In support of this, when anti-C. jejuni O:41 antisera are adsorbed in a similar way, all subsequent reactions of the adsorbed antisera are reduced or absent.
Consistent with the serological findings of our study, structural analyses showed the presence of GM 1 mimicry in the form of a tetrasaccharide in the core OS of C. jejuni 16971. 94GSH. Collectively, the results of the present study show that C. jejuni O:41 GBS isolates exhibit mimicry of the GM 1 ganglioside as does a C. jejuni enteritis isolate. However, mimicry of the GM 1 ganglioside by the core OS of C. jejuni O:41 is not limited to strains associated with GBS, since LPS from the enteritis strain reacted in a similar but not identical way to the GBS-associated LPS. This phenomenon has previously been observed by us with C. jejuni O:19 LPS (34), whereby an enteritis isolate mimics both the GM 1 and GD 1a gangliosides and a GBS isolate mimics the GM 1 ganglioside. We suggested that a further attribute of the bacterium or the host contributed to the development of GBS. Mimicry by O side chains of C. jejuni O:19 LPS of hyaluronic acid was demonstrated, and an increased expression of O side chains was noted in strains associated with GBS (33) . Although the mimicry of the GM 1 ganglioside in the core OS of C. jejuni O:41 LPS is the same as that exhibited by other C. jejuni serotypes associated with GBS, the presence of similar mimicry in the core OSs of enteritis strains suggests that other bacterial and/or host attributes are involved in disease development. On the other hand, differences between the LPSs of C. jejuni O:41 strains in their reactions with antiganglioside antibodies (e.g., anti-asialoGM 1 antibodies) may indicate the presence of slight differences in sugar substitution in the core OS or in the presentation of epitopes in the different LPSs. Whether these factors play a role in disease development requires further investigation.
